8-KThe WireStrategic
Material Agreement · Company Update
Filed Apr 27, 2026 · 2mo ago · Accession 0001193125-26-179529
Plain English
Ligand Pharmaceuticals Incorporated entered into a merger agreement to acquire XOMA Royalty Corporation, which will involve a cash payment and contingent value rights for XOMA Royalty shareholders.
Filing details
- Company
- LIGAND PHARMACEUTICALS INC
- Ticker
- LGND
- CIK
- 886163
- Form type
- 8-K
- Filing date
- Apr 27, 2026
- Report date
- Apr 27, 2026
- Document
- d143046d8k.htm
- Size
- 4.2 MB